Trial · NCT07881133
Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery
NCT07881133, Not applicable, Recruiting, Bucharest Emergency Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery. Trials, record NCT07881133. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07881133
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery
- NCT number
- NCT07881133
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 320 participants, estimated
- Lead sponsor
- Bucharest Emergency Hospital
- Conditions
- Colorectal (Colon or Rectal) Cancer, STOMACH NEOPLASM
- Interventions
- Perioperative Biomarker-Guided Monitoring
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Predictive Performance of Perioperative Biomarkers for Postoperative Complications | Up to 30 days after surgery. | The predictive performance of perioperative procalcitonin, lactate, and blood glucose levels for postoperative complications will be assessed using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC). Postoperative complications, including infections and anastomotic leakage, will be assessed within 30 days after surgery. |
| Secondary | Incidence of Postoperative Infections | Up to 30 days after surgery | Proportion of participants developing at least one clinically diagnosed postoperative infection, including surgical site infections and intra-abdominal infections, within 30 days after colorectal or gastric cancer surgery. The incidence will be compared between the intervention and control groups. |
| Secondary | Incidence of Anastomotic Leakage | Up to 30 days after surgery | Proportion of participants developing clinically or radiologically confirmed anastomotic leakage following colorectal or gastric cancer surgery. The incidence of anastomotic leakage will be compared between the intervention and control groups. |
| Secondary | Length of Hospital Stay | From the date of surgery until hospital discharge, assessed up to 30 days | Duration of postoperative hospitalization, measured in days from the date of surgery to hospital discharge. The length of hospital stay will be compared between the intervention and control groups. |
| Secondary | 30-Day All-Cause Mortality | Up to 30 days after surgery | Proportion of participants who die from any cause within 30 days after surgery. Mortality rates will be compared between the intervention and control groups. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07881133
GET https://conductscience.org/api/trials/v1/NCT07881133/registered